Stocksigma LogoStocksigma Logo

CARE Ratings Upgrades Brooks Laboratories' Bank Facilities to CARE BB+ and CARE A4+

CARE Ratings upgraded Brooks Laboratories Limited’s long-term bank facilities (₹7.80 crore) to CARE BB+; Stable from CARE BB; Stable, and short-term

CARE Ratings Upgrades Brooks Laboratories' Bank Facilities to CARE BB+ and CARE A4+

Brooks Laboratories Ltd · Others (Uncategorized) · 12 Nov 2026, 11:44 pm

CARE Ratings Upgrades Brooks Laboratories' Bank Facilities to CARE BB+ and CARE A4+ CARE Ratings upgraded Brooks Laboratories Limited’s long-term bank facilities (₹7.80 crore) to CARE BB+; Stable from CARE BB; Stable, and short-term facilities (₹4.20 crore) to CARE A4+ from CARE A4 on 12th Nov'26. The upgrade reflects strengthened liquidity following ₹106.33 crore received from a 16.33% stake divestment in Brooks Steriscience, turning the firm net debt-free to fund internal capex. Corporate guarantee exposure fell to ~₹48.15 crore from ~₹116.77 crore in FY26. FY26 PBILDT margins improved to 8.88% (FY25: 6.03%), with revenues at ₹86.26 crore.

Original exchange filing (PDF)

More announcements from Brooks Laboratories Ltd

All Brooks Laboratories Ltd announcements